Development of a novel Bruton's tyrosine kinase inhibitor that exerts anti-cancer activities potentiates response of chemotherapeutic agents in multiple myeloma stem cell-like cells

Elbezanti, WO; Al-Odat, OS; Chitren, R; Singh, JK; Srivastava, SK; Gowda, K; Amin, S; Robertson, GP; Nemmara, VV; Jonnalagadda, SC; Budak-Alpdogan, T; Pandey, MK

Pandey, MK (通讯作者),Rowan Univ, Cooper Med Sch, Dept Biomed Sci, Camden, NJ 08103 USA.

FRONTIERS IN PHARMACOLOGY, 2022; 13 ():